The clinical prognosis of patients with high-grade glioma was predicted non-invasively in this study by analyzing the expression level of PDPN using an enhanced MRI-based radiomics model, which was constructed using a gradient boosting machine in conjunction with transcriptomics. Here, PDPN is linked to glioma.